InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Carroll Jill, Chief Financial Officer. Officer active across 2 companies, notably Arcellx, Inc.. Cumulatively, 9 reports have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €97.8m. History available since 8 February 2022. The latest transaction was filed on 1 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Carroll Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,419,298 sharesCommon StockSEC:0001193125-26-201894:0
489,486 sharesCommon StockSEC:0001193125-26-201894:1
277,778 shares@ US$18.000.40% mcap100.0% of flowCommon StockSEC:0001193125-26-201894:2
Canonical exit: 30 Jul 2026 (T+90)
1,479,148 sharesCommon StockSEC:0001193125-26-188029:0
504,263 shares@ US$70.5534.8% of flowCommon StockSEC:0000950170-24-036013:0
504,263 shares@ US$49.1324.3% of flowCommon StockSEC:0001209191-23-058974:0
315,164 shares@ US$41.5013.1% of flowCommon StockSEC:0001209191-23-033867:0
631,932 shares@ US$45.0027.8% of flowCommon StockSEC:0001209191-23-029613:0
3,400,144 shares0Common StockSEC:0001209191-22-008157:0
9 of 9 declarations
About Carroll Jill
Suping (Sue) Cheung is the Chief Financial Officer of MARRONE BIO INNOVATIONS INC. In this role, she oversees the company's financial management, including financial planning and regulatory compliance. Suping is committed to ensuring the financial health of the organization and supporting its growth.
